Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00401401 | Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 30 | GenmabINDUSTRY | 5 | Dec 23, 2011 | clinicaltrials |
| NCT01256853 | Modified Vaccinia Ankara (MVA) Vaccine Study | completed | Phase 1 | 18 | Chinese University of Hong KongOTHER | 1 | Dec 22, 2011 | clinicaltrials |
| NCT01313390 |
| Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer(DORA) |
| terminated |
| Phase 1 / Phase 2 |
| 4 |
| University College, LondonOTHER |
| 1 |
| Dec 12, 2011 |
| clinicaltrials |
| NCT00410865 | Wild Type p53 Adenovirus for Oral Premalignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00937300 | T-cell Based Immunotherapy for Head and Neck Cancer | withdrawn | Phase 1 | 0 | Inge Marie SvaneOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01449942 | Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) | completed | Phase 1 / Phase 2 | 40 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00629226 | Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00507858 | Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer | completed | Phase 1 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00023790 | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT01149902 | Study of Chemo-Immunotherapy in Head and Neck Cancer Patients | unknown | Phase 1 | 10 | University of YamanashiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00004048 | Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer | completed | Phase 1 / Phase 2 | 30 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00357617 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 24 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00584597 | A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis(TRAUMEEL) | completed | Phase 1 | 14 | University of OklahomaOTHER | 1 | Dec 13, 2010 | clinicaltrials |
| NCT00681967 | Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer(IRESSA&H&N) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00406289 | Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor | completed | Phase 1 | 24 | University Hospital, GhentOTHER | 1 | Sep 6, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00077103 | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer | terminated | Phase 1 / Phase 2 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005647 | SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck | completed | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00185835 | Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck | completed | Phase 1 | 10 | Stanford UniversityOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00268671 | Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) | completed | Phase 1 / Phase 2 | 45 | SanofiINDUSTRY | 0 | Dec 7, 2009 | clinicaltrials |
| NCT00114153 | Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 1 | 48 | University of VirginiaOTHER | 1 | Nov 26, 2009 | clinicaltrials |
| NCT01007240 | Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles | unknown | Phase 1 | 10 | Hadassah Medical OrganizationOTHER | 0 | Nov 4, 2009 | clinicaltrials |
| NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 | 29 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00540332 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy | withdrawn | Phase 1 / Phase 2 | 0 | Swedish Orphan BiovitrumINDUSTRY | 0 | Mar 2, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00001442 | A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00078494 | Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | completed | Phase 1 | 99 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00239304 | Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00195078 | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 29 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00080028 | Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | terminated | Phase 1 | 18 | Pharmacyclics LLC.INDUSTRY | 1 | May 8, 2007 | clinicaltrials |
| NCT00028405 | Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors | completed | Phase 1 | 48 | Light Sciences LLCINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Dec 23, 2011source: clinicaltrials